Advertisement
Advertisement
TIL
Instil Bio, Inc. Common Stock
7.13
USDSponsored
-0.08
-1.17%
Feb 03, 15:59 UTC -5
Closed
After-Market
7.10
-0.03
-0.36%
TIL Earnings Reports
Positive Surprise Ratio
TIL beat 7 of 19 last estimates.
37%
Next Report
Date of Next Report
Mar 02, 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/-$2.04
Implied change from Q3 25 (Revenue/ EPS)
--
/+2.00%
Implied change from Q4 24 (Revenue/ EPS)
--
/+12.09%
Instil Bio, Inc. Common Stock earnings per share and revenue
On Nov 13, 2025, TIL reported earnings of -2.00 USD per share (EPS) for Q3 25, beating the estimate of -2.37 USD, resulting in a 15.50% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -7.20% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 5 analysts forecast an EPS of -2.04 USD, with revenue projected to reach -- USD, implying an increase of 2.00% EPS, and increase of 0.00% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
AYTU BioPharma, Inc. Common Stock
Report Date
Feb 03, 2026 For Q2 26
Estimate
-$0.61
Actual
-$1.05
Surprise
-71.57%
Amgen Inc
Report Date
Feb 03, 2026 For Q4 25
Estimate
$4.82
Actual
$5.29
Surprise
+9.56%
Regeneron Pharmaceuticals Inc
Report Date
Jan 30, 2026 For Q4 25
Estimate
$10.84
Actual
$11.44
Surprise
+5.52%
Twist Bioscience Corporation Common Stock
Report Date
Feb 02, 2026 For Q1 26
Estimate
-$0.43
Actual
-$0.50
Surprise
-14.00%
Nurix Therapeutics, Inc. Common stock
Report Date
Jan 28, 2026 For Q4 25
Estimate
-$0.88
Actual
-$0.82
Surprise
+7.66%
FAQ
What were Instil Bio, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Instil Bio, Inc. Common Stock reported EPS of -$2.00, beating estimates by 15.5%, and revenue of $0.00, 0% as expectations.
How did the market react to Instil Bio, Inc. Common Stock's Q3 2025 earnings?
The stock price moved down -7.2%, changed from $14.99 before the earnings release to $13.91 the day after.
When is Instil Bio, Inc. Common Stock expected to report next?
The next earning report is scheduled for Mar 02, 2026.
What are the forecasts for Instil Bio, Inc. Common Stock's next earnings report?
Based on 5
analysts, Instil Bio, Inc. Common Stock is expected to report EPS of -$2.04 and revenue of -- for Q4 2025.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement